---
ID: 3763
post_title: 'Theranos voids two years of Edison test results: WSJ'
author: Staff Writer
post_date: 2016-05-19 06:31:09
post_excerpt: ""
layout: post
permalink: >
  https://www.whenitson.com/theranos-voids-two-years-of-edison-test-results-wsj/
published: true
original_cats:
  - domesticNews
original_title:
  - 'Theranos voids two years of Edison test results: WSJ'
original_link:
  - >
    http://feeds.reuters.com/~r/Reuters/domesticNews/~3/7HQSnwoGN50/us-theranos-regulations-idUSKCN0YA082
canonical_url:
  - >
    http://feeds.reuters.com/~r/Reuters/domesticNews/~3/7HQSnwoGN50/us-theranos-regulations-idUSKCN0YA082
---
 [ad_1]
<br><div id="articleText">
<span id="midArticle_start"/>

<span class="focusParagraph" readability="6"><p><span class="articleLocatio&lt;/span&gt;n">Blood-testing firm Theranos Inc notified the U.S. federal health regulators that it voided results from its Edison blood-testing devices for two years, the Wall Street Journal reported on Wednesday, citing a person familiar with the matter.</span></p></span><span id="midArticle_0"/><p>The company informed the Centers for Medicare and Medicaid Services that it has issued tens of thousands of corrected blood-test reports to doctors and patients, nullifying some results and revising others, the Journal reported, citing a person familiar with the matter. </p><span id="midArticle_1"/><p>The corrected reports include the Edison results and many tests run on traditional laboratory machines, the Journal said.</p><span id="midArticle_2"/><p>"...we've taken comprehensive corrective measures to address the issues CMS raised in their observations. As these matters are currently under review, we have no further comment at this time," a Theranos spokeswoman said in an email. </p><span id="midArticle_3"/>
        
        <span class="first-article-divide"/><p>In April, U.S. federal health regulators had proposed banning the company's founder, Elizabeth Holmes, from the blood-testing business for at least two years after determining that the company failed to fix deficiencies at its California laboratory.</p><span id="midArticle_4"/>
        
        <span class="second-article-divide"/><p>The blood-testing firm which expanded its board to include Dr. Fabrizio Bonanni, a former Amgen Inc and Baxter International Inc executive, has been under investigation by several U.S. regulators in the recent past.</p><span id="midArticle_5"/><p>Centers for Medicare and Medicaid Services was not immediately available for comment. </p><span id="midArticle_6"/>
        
        <span class="third-article-divide"/><span id="midArticle_7"/><p> (Reporting by Vishal Sridhar in Bengaluru; Editing by Sunil Nair)</p><span id="midArticle_8"/></div>
<br>[ad_2]
<br><a href="http://feeds.reuters.com/~r/Reuters/domesticNews/~3/7HQSnwoGN50/us-theranos-regulations-idUSKCN0YA082">Source </a>